No Data
No Data
Express News | Akoya Biosciences Inc : Stephens Cuts Target Price to $4 From $4.5
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Cuts Target Price to $4
Express News | Piper Sandler Maintains Overweight on Akoya Biosciences, Lowers Price Target to $4
Express News | Akoya Biosciences Inc : Piper Sandler Cuts Target Price to $4 From $6
Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint
Akoya Biosciences | 10-Q: Q2 2024 Earnings Report